Patients with a biopsy-proven benign bone tumor for which standard of care is intralesional
operative management will receive a weight-appropriate IV dose of indocyanine green (ICG,
FDA-approved) the day prior to surgery during their standard pre-operative clinic visit. On
the day of surgery, fluorescence images will be obtained using a non-invasive fluorescence
camera.